Recent advancements in the field of experimental structural biology have provided highresolution structures of active and inactive state G protein-coupled receptors (GPCRs), a highly important pharmaceutical target family, but the process of transition between these states is poorly understood. According to the current theory, GPCRs exist in structurally distinct, dynamically interconverting functional states of which populations are shifted upon binding of ligands and intracellular signaling proteins. However, explanation of the activation mechanism on an entirely structural basis gets complicated when multiple activation pathways and active receptor states are considered. Our unbiased, atomistic molecular dynamics simulations of the mu-opioid receptor in a physiological environment revealed that external stimulus is propagated to the intracellular surface of the receptor through subtle, concerted movements of highly conserved polar amino acid side chains along the 7 th transmembrane helix. To amend the widely accepted theory we suggest that the initiation event of GPCR activation is the shift of macroscopic polarization between the ortho-and allosteric binding pockets and the intracellular G protein-binding interface.
INTRODUCTION
G protein-coupled receptors (GPCRs) are located on cell surfaces and act as communication interfaces for external stimuli exerted by structurally diverse molecules. Upon activation GPCRs initiate signal transduction through interactions with G proteins and arrestins, and control a variety of intracellular processes. Owing to this, approximately 34% of all prescription pharmaceuticals target members of this receptor family. 1 However, application of such drugs is often limited by a number of unwanted side effects due to non-selective activation of multiple GPCRs, or multiple signaling pathways associated with one receptor. The most recent challenge of rational drug design is, therefore, to develop signaling pathway-specific, or in other words 'functionally selective' GPCR agonists. To address this challenge, complete understanding of the structural mechanism of GPCR activation is necessary. Opposed to the high diversity of external activators, signaling is mediated by only a few types of G proteins, advocating that GPCR activation may follow a general mechanism.
The structure of GPCRs consists of a conserved bundle of seven transmembrane αhelices and highly dynamic extracellular and cytosolic domains of various lengths. Highresolution experimental structures are available for many GPCRs both in the active and inactive states (see http://gpcrdb.org), 2 but the mechanism of transition between these forms is intensely debated. The most conspicuous difference between the active and inactive class A GPCR structures, published to this date, is a notable disposition of the 6 th transmembrane helix (TM6). [3] [4] However, such large dispositions were shown to occur even in the absence of a bound ligand, due to the inherent dynamics of the receptor structure, or may originate from the applied conditions of crystallographic structure determination, namely the attachment of fusion proteins or the application of crystallization chaperones. [5] [6] [7] Apart from TM6 disposition, a possible role of intracellular loop 1 (ICL1) and the cytosolic helix (H8) in the activation mechanism was highlighted by dynamic NMR measurements of the mu-opioid receptor. 8 Comparison of the structures of active and inactive state mu-and delta-opioid receptors suggested that an extended network of polar amino acids and water molecules connects the orthosteric ligand binding pocket to the cytosolic domains which may be functionally relevant. The highly conserved E/DRY, NPxxY and CWxP functional motifs as well as allosteric Na + binding sites have been specified to participate in the activation mechanism of class A GPCRs. 9 Conceivably, activation signal is transmitted to the intracellular surface of the receptor through the interplay of these microswitches, however, no direct evidence of such integral mechanism has yet been given.
Real-time observation of such processes using conventional experimental techniques is unattainable.
A significant part of the now widely accepted theory of GPCR activation was provided by landmark molecular dynamics (MD) simulation studies. [3] [4] [10] [11] According to this theory, GPCRs exist as a dynamic ensemble of multiple active, inactive and intermediate states. The populations of active states is increased by agonist binding and the stabilization of an active structure facilitates the insertion of G proteins. 10 The growing number of evidence of pre-coupled GPCR-G protein complexes in the absence of ligands, however, presents a challenge to the above hypothesis. 12 In general, explanations given on an entirely structural basis are often diffuse and fail to provide unequivocal suggestion for a possible structural mechanism of GPCR activation, especially when multiple active states, or structurally similar but functionally different ligands are considered. Further limitations of previous MD studies are that simulation systems were confined to the TM region of GPCRs, embedded in very simplistic representations of the cell membrane. Most recently, special effects of charged interfacial lipids on  2 -adrenergic receptor signaling was demonstrated, drawing attention to the importance of accurate membrane representation. 13 The mu-opioid receptor is one of the most extensively studied GPCRs therefore appropriately represents the general structural features of class A (rhodopsin-like) GPCRs. In order to get a deeper insight, we have performed all-atom MD simulations of the mu-opioid receptor on a s timescale, in a physiologically relevant setup. Simulations of the active and inactive receptors were executed in caveolar membrane environment, in the presence of the endogenous agonist endomorphin-2 (EM2) 14 and the G i protein complex, or beta-arrestin-2. In addition, control simulations were carried out with fused T4-lysozyme or intacellularly bound Nb39 nanobody, representing the previously applied crystallization conditions. 5,7
METHODS

System building
The crystallographic structures used in this study were downloaded from the Brookhaven Protein Data Bank (http://www.rcsb.org): active mu-opioid receptor (pdb code: 5C1M), inactive mu-opioid receptor (pdb code: 4DKL), heterotrimeric G i protein complex (pdb code: 1GP2), Nb39 nanobody (pdb code: 5C1M), T4-lysozyme (pdb code: 4DKL), β 2 -adrenergic receptor complexed with G s protein (pdb code: 3SN6) and rhodopsin complexed with beta-arrestin-2 (pdb code: 4ZWJ). These latter two structures were used as templates to orient the G i protein complex and beta-arrestin-2 to the mu-opioid receptor. The full sequence of the murine mu-opioid receptor (UniProtKB-P42866-OPRM1) was obtained from UniProt (http://www.uniprot.org), and the coordinates of the membrane orientation from the OPM server (http://opm.phar.umich.edu) The crystallization chaperone and fusion protein (Nb39 nanobody and T4-lysozyme, respectively) were removed from the crystallographic structures. The Swiss-PdbViewer was used to retrieve all missing, modified or mutated residues of the transmembrane (TM) domain of the receptor. GTP was generated in CHARMM-GUI (http://www.charmmgui.org) and edited manually to replace GDP in the G i complex.
The exclusion of the drag posed by the mass of the N-and C-terminal domains may provide unrealistic results for the dynamics of transmembrane helices. To model the missing Nand C-terminal domains 10 ns folding simulations of the N-and C-terminal domains were performed using the GROMACS ver. 5.1.4 program package, the AMBER ff99SB-ILDN-NMR force field and GB/SA implicit solvation. During MD simulations, the system temperature was set to 310 K and maintained by the v-rescale algorithm. Ten parallel simulations were run for both the N-and C-terminal domains from where the resultant, folded structures were evaluated and selected based on the compactness, accessibility of post-translational modification-and TM region attachment sites. Glycosylation sites were predicted using the NetNGlyc 1.0 online server. 15 The selected domain structures were linked to the TM region using Pymol ver. 2.1.0.
Four intracellular partners were used in this study, namely the heterotrimeric G i protein, beta-arrestin-2, Nb39 nanobody and T4-lysozyme. Among them the last two were used as control reference simulation systems. The first three proteins were attached non-covalently to the receptor while T4-lysozyme was fused with the receptor replacing the third intracellular loop (ICL3), similarly to that in the crystallographic structure of the inactive mu-opioid receptor (pdb code: 4DKL).
CHARMM-GUI was used to include various post-translational modifications as well as
to build membrane bilayers. Complex type glycans were added to the N-terminal domain, containing a common core (Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc1-N) and sialic 6 acid (N-acetylneuraminic acid) at glycosylation prone N9, N31 and N38 residues of the Nterminal domain. 16 Phosphorylation of S363 and T370 were done for all the complexes, while S375, T376 and T379 sites at the C-terminal domain were phosphorylated in addition for the arrestin complexes. 17 The C170 residue of ICL2 was palmitoylated. 18 A caveolar membrane environment, considered to be the physiological environment of the mu-opioid receptor, was built using the membrane builder tool of CHARMM-GUI.
CHARMM36 parameters were used to build complex, multicomponent membrane systems
, palmitoyl-sphingomyelin (PSM-9.9%) and monosialodihexosylganglioside (GM3-5%). 19 GM3 gangliosides were generated separately using the glycoprotein builder tool of CHARMM-GUI, and then added manually to the membrane. The asymmetric upper and the lower leaflet membrane compositions were specified in a most probable ratio. 20 The membrane builder was also used to embed the glycosylated, palmitoylated and phosphorylated full sequence model of the mu-opioid receptor into the membrane. Systems were then solvated explicitly with TIP3P water molecules in a hexagonal shaped periodic box, and sodium and chloride ions (0.15 M) were added to neutralize the net charge and to attain physiological ionic strength. System coordinates and topologies were generated in GROMACS format. 
MD simulations
All equilibration and production MD simulations were performed using the GROMACS ver. 5.1.4. molecular dynamics program package. Eight independent simulations were performed, four each for inactive and active mu-opioid receptors, complexed with heterotrimeric G i protein, beta-arrestin-2, Nb39 nanobody and T4-lysozyme. After orienting and adding EM2, the resultant complex systems were energy minimized thoroughly performing 5000 steps steepest descent, followed by 5000 steps conjugate gradient minimization with convergence criteria of 1000 kJ/mol nm -1 in both cases. After minimization, systems were subjected to a sixstep equilibration protocol of positionally restrained MD simulations in the NVT and then, after 2 steps, in the NPT ensemble at 303.15 K and 1 bar, having the positional restraints on the heavy atoms of the proteins and membrane constituents decreasing gradually. The first three equilibration MD runs were done for 25 ps in 1 fs time steps, and the following three was continued for 100 ps in 2 fs time steps. The following, further parameters were applied: the LINCS algorithm was used to constrain all bonds to their correct length, temperature was regulated by the v-rescale algorithm with a coupling constant of 1 ps, semi-isotropic pressure coupling was applied with a coupling constant of 5 ps and compressibility of 4.5 x 10-5 bar -1 .
The PME method was used to calculate energy contributions from non-bonded interactions with all cut-off values set to 1.2 nm. After equilibration, production simulations were performed for 1 s at 310 K in the NPT ensemble, with other parameters same as above. The coordinates were stored in every 5000th steps yielding trajectories of 100.000 snapshots.
MD trajectory analysis
Analysis of MD trajectories was performed using the analysis suite of the GROMACS Figure S1 ). This is in line with previous simulation results, where notable TM helix rearrangements were only observed at longer timescales and in the absence of bound intracellular proteins. 10 Initial conformations of ICL1 and H8 were maintained throughout simulations in each receptor state, regardless of the intracellular interacting partners ( Figure S2-S3 ). The second intracellular loop (ICL2), on the other hand, adopted a stable helical structure when bound by beta-arrestin-2 and partially unfolded upon interaction with the G i  subunit, independent of the state of the receptor ( Figure S4 ). In the active states, increased frequency of intermolecular hydrogen bonds was observed involving ICL2, helix 5 of G i and the finger-and C-loops of beta-arrestin-2 ( Figure 1 , Table S1 ). These observations indicate that the conformations of ICL1 and H8 are controlled by the receptor state, whereas ICL2 adapts its structure to the bound signaling proteins, therefore may be partially responsible for signaling pathway specificity. Such dynamics of ICL2 was not indicated by the published high resolution structures of this receptor. [5] [6] [7] Secondary structure analysis of the control systems with Nb39 or T4-lysozyme fusion suggests that these systems better represent the arrestin-bound state of the receptor ( Figure S4 ). (Table 1) indicated, in agreement with previous proposals, 7 that interactions between D164 3.49 and R165 3.50 of the DRY motif were more frequent in the inactive states. Specific role of the previously reported DRY-TM5, 7 DRY-TM6, 7 CWxP-TM7 24 and NPxxY-TM 5 contacts in the activation mechanism was not substantiated by the simulation results. No systematic connection was found between the frequency of those interactions and physiologically relevant receptor states and complexes. A salt bridge between R165 3.50 (DRY) and D340 8.47 (H8), however, was found to be present only in the active state and most frequent in the presence of the G i protein complex. This specific interaction was not described previously as, opposed to the above mentioned contacts, it was not evidently present in the reported high resolution structures. [5] [6] [7] Our data suggest that this contact may be important for receptor activation and it is further supported by earlier mutation experiments. 25 13 Dynamic cross-correlation analysis of the transmembrane domain and the extra-and intracellular loops provided the most striking results (Figure 2 ). According to those, the orthosteric binding pocket is connected to the intracellular surface through a channel of polar amino acid residues, of which motions are highly correlated (Figure 3 ). Such concerted motions were observed only for the active receptor-G i protein complex (Figure 3, Figures S5-S9 ),
Analysis of intramolecular salt bridges and H-bonds between conserved motifs
suggesting that this phenomenon has a fundamental role in G protein-mediated signaling.
Residues of this polar signaling channel are located mostly on the 7 th transmembrane helix (TM7), in the inner region of the transmembrane helical bundle, most distant from the surrounding membrane environment. All channel residues are parts of highly conserved functional motifs and allosteric Na + binding sites, except for Y326 7.43 of the binding pocket and N340 8.47 at the G protein-binding interface. The increased variability of these residues is associated with ligand and G protein specificity, respectively. Analysis of the individual dynamics of these specific side chains revealed that the observed movements are small and mostly occur without the transition between rotameric states (Table S2 ). Considering that the orientation of amino acid side chains in the orthosteric binding pocket of the mu-opioid receptor are nearly identical in the agonist-5,6 and antagonist-bound states 7 , our results suggest that the underlying event of receptor activation is the change of macroscopic polarization in a shielded central duct of the transmembrane domain. Although classical force field methods cannot provide quantitative details of such mechanism, independent mutation data provides direct evidence for the interplay of these polar and charged amino acid side chains during receptor activation. Impaired G protein signaling or elevation of constitutional activity was observed for mutant receptors, where residues of the above mentioned polar signaling channel were replaced, 9, [24] [25] [26] [27] [28] [29] [30] [31] [32] while receptor activity was preserved in double mutants, where the net charge of channel residues was kept intact. 28 The shift of macroscopic polarization may be assisted by the inherent dipole moments of TM helices. Generally, a more ordered -helical segment possesses a higher dipole moment, which can participate in various conduction processes. 33 Analysis of the evolution of helix properties during simulations exhibited that TM7 is the most ordered among the TM helices of the active, G i protein-bound receptor. Furthermore, the helicity of TM7 is closest to ideal when the receptor is G i protein-bound and least ideal when complexed by beta-arrestin-2 (Figure 4 ).
This accentuates the role of TM7 in the activation mechanism and it is corroborated by previous reports. 9, 34 The role of electrostatic forces and the importance of charge balance is further supported by the known effect of elevated concentrations of Na + ions 35 and the concept of voltage sensing. [36] [37] According to this latter, changes in the transmembrane electrostatic potential (V m ) resulting from the rearrangement of charged species and polar membrane components could elicit functional effects in GPCRs.
CONCLUSION
The above results and considerations, as well as comparison to published mutation data have led us to suggest that large scale structural rearrangements may not be the key event of receptor activation. According to our alternative hypothesis, structural changes induced by agonist binding are subtle and the signal transduction mechanism is rather initiated by the perturbation of electrostatic balance within the binding pocket. Such perturbation is then propagated to the intracellular G protein-binding interface through the minuscule rearrangement of polar amino acid side chains of highly conserved structural motifs, located along TM7, and this charge shift is assisted by the inherent dipole moment of that helical segment. This 
